Arcutis Biotherapeutics, Inc. - Common stock —— 资产负债表 (NASDAQ:ARQT) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 298.27 M408.15 M449.27 M341.37 M348.89 M432.97 M 负债总额 27.65 M110.47 M239.69 M252.7 M191.35 M243.49 M 权益总额 270.62 M297.68 M209.58 M88.67 M157.54 M189.48 M 负债及股东权益总额 298.27 M408.15 M449.27 M341.37 M348.89 M432.97 M 总债务 —72.35 M197.77 M201.8 M107.2 M108.96 M 净债务 —72.35 M197.77 M201.8 M107.2 M-113.02 M

新闻

Arcutis Biotherapeutics: The Dermatology Platform Is Starting To Compound (NASDAQ:ARQT)

Arcutis Biotherapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ARQT) 2026-05-07

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Beats Revenue Estimates

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Will Arcutis Biotherapeutics, Inc. (ARQT) Report Negative Earnings Next Week? What You Should Know

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Arcutis公布幼儿湿疹乳膏的长期数据

Arcutis reports long-term data on eczema cream for young children

Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial

Arcutis at TD Cowen Conference: Strategic Growth Insights

瑞穗因成本上升将Arcutis目标价下调至35美元